Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or radiotherapy ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

Prostate cancer has four stages. These stages show how much the cancer has grown and spread in the body. Knowing the stage helps doctors choose the right treatment and understand the outlook. After ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...